Ireland South MEP Sean Kelly has already warned that the EU must stand by Ireland and protect our tech and pharma sector in the face of threats from the US. In this latest outburst, Secretary Luttnick ...
Tech stocks, like Microsoft, demonstrate strong growth due to AI integration, raising investor interest. Nvidia's gains in AI-driven data center revenue signal robust sector opportunities. Apple's ...
A key drug in this class, semaglutide is set to go off-patent in March next year, and several Indian players, including Mankind Pharma Limited, Alkem Labs Limited, and Dr. Reddy’s Laboratories ...
But while the headlines spout flat numbers like 20 percent on Chinese imports and 25 percent on steel, the tariffs’ effect on tech gear isn’t as clear cut. To understand the whole situation ...
The life sciences sector accounted for 49.3% of total investment in Pittsburgh’s tech economy last year, followed by software and hardware, which collectively represented 22.9% and 26.84%, ...
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...
Not content to wait for open letters to influence the European Commission, Dutch parliamentarians have taken matters into their own hands by passing eight motions urging the government to ditch ...
Alphabet Inc.’s Google was warned to step in line with the European Union’s Big Tech rules or risk hefty fines as part of a two-pronged escalation against Silicon Valley that risks further ...
Speaking on the "Verdict with Ted Cruz" podcast, Musk singled out three tech industry leaders—Oracle co-founder Larry Ellison, Amazon founder Jeff Bezos, and Google co-founder Larry Page—as ...
Previously at the epicenter of the U.S. opioid crisis, Purdue Pharma is looking to reenter the public lexicon as a new public benefit company. After a prior bankruptcy settlement was nixed by the ...
Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.